Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Richard Broek Den Van


  • Director at Celldex Therapeutics Inc. (CLDX), 2016-06-09
  • Director at Special Diversified Opportunities Inc. (SDOI), 2015-06-25
  • Director at Pharmacyclics Inc (PCYC), 2015-05-28
  • Director at Response Genetics Inc (RGDX), 2014-07-12
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
RGDX $1.50 100,000 Director 282,700 2012-02-02 Filing
SDIX $1.88 9,900 Director 30,630 2010-08-23 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SDOI $1.11 75,000 Director 0 2014-12-24 Filing
SDOI $1.11 25,000 Director 75,000 2014-12-23 Filing
SDOI $1.12 50,000 Director 130,000 2014-12-18 Filing
SDOI $1.11 20,000 Director 180,000 2014-12-17 Filing
PCYC $144.92 25,000 Director 29,610 2014-02-27 Filing